Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?
Research on functions and signalling pathways of insulin has traditionally focused on peripheral tissues such as muscle, fat and liver, while the brain was commonly believed to be insensitive to the effects of this hormone secreted by pancreatic beta cells. However, since the discovery some 30 years ago that insulin receptors are ubiquitously found in the central nervous system, an ever-growing research effort has conclusively shown that circulating insulin accesses the brain, which itself does not synthesise insulin, and exerts pivotal functions in central nervous networks. As an adiposity signal reflecting the amount of body fat, insulin provides direct negative feedback to hypothalamic nuclei that control whole-body energy and glucose homeostasis. Moreover, insulin affects distinct cognitive processes, e.g. by triggering the formation of psychological memory contents. Accordingly, metabolic and cognitive disorders such as obesity, type 2 diabetes mellitus and Alzheimer's disease are associated with resistance of central nervous structures to the effects of insulin, which may derive from genetic polymorphisms as well as from long-term exposure to excess amounts of circulating insulin due to peripheral insulin resistance. Thus, overcoming central nervous insulin resistance, e.g. by pharmacological interventions, appears to be an attractive strategy in the treatment and prevention of these disorders. Enhancement of central nervous insulin signalling by administration of intranasal insulin, insulin analogues and insulin sensitisers in basic research approaches has yielded encouraging results that bode well for the successful translation of these effects into future clinical practice.
Hallschmid
M
M
Department of Neuroendocrinology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. hallschmid@kfg.uni-luebeck.de
Schultes
B
B
D001812:Blood-Brain Barrier; D001921:Brain / Q000502:physiology / Q000503:physiopathology; D002490:Central Nervous System / Q000503:physiopathology*; D003072:Cognition Disorders / Q000209:etiology / Q000503:physiopathology*; D002149:Energy Intake; D004734:Energy Metabolism; D005943:Gluconeogenesis; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology*; D000078790:Insulin Secretion; D008066:Lipolysis; D008659:Metabolic Diseases / Q000209:etiology / Q000503:physiopathology*; D011972:Receptor, Insulin / Q000502:physiology; D015398:Signal Transduction
D007328:Insulin; D011972:Receptor, Insulin
Brain Res. 1995 Sep 18;692(1-2):278-82
8548316
Int J Obes Relat Metab Disord. 2004 Sep;28 Suppl 2:S41-6
15306837
N Engl J Med. 2008 Dec 11;359(24):2558-66
19073975
PLoS One. 2007 Nov 21;2(11):e1196
18030331
BMC Neurosci. 2008 Dec 10;9 Suppl 3:S5
19091002
Neuroendocrinology. 2001 Oct;74(4):270-80
11598383
Endocr Rev. 2008 Jun;29(4):494-511
18436709
Diabetes Care. 1991 Aug;14(8):728-31
1954809
Diabetes. 2004 Sep;53(9):2202-8
15331528
Peptides. 1990 May-Jun;11(3):467-72
2199946
Diabetes. 2006 Apr;55(4):978-87
16567519
Diabetologia. 2007 Dec;50(12):2602-3
17917711
Diabetes. 1993 Feb;42(2):263-72
8425662
J Alzheimers Dis. 2008 Apr;13(3):323-31
18430999
Psychoneuroendocrinology. 2004 Nov;29(10):1326-34
15288712
Am J Geriatr Psychiatry. 2005 Nov;13(11):950-8
16286438
Int J Obes (Lond). 2008 Feb;32(2):275-82
17848936
Nat Neurosci. 2002 Jun;5(6):566-72
12021765
J Clin Endocrinol Metab. 1999 Sep;84(9):3041-6
10487662
Science. 2005 Jan 21;307(5708):375-9
15662002
Neuropsychopharmacology. 2007 Jan;32(1):239-43
16936707
Eur J Pharmacol. 2008 Jul 28;589(1-3):176-9
18602098
Nat Med. 2002 Dec;8(12):1376-82
12426561
Endocrinology. 1987 Nov;121(5):1611-5
3311715
Physiol Behav. 2006 Nov 30;89(4):611-6
17045623
Diabetes. 2009 Mar;58(3):637-40
19095760
Neurology. 1998 Jan;50(1):164-8
9443474
Nat Neurosci. 2008 Mar;11(3):309-17
18278039
Psychoneuroendocrinology. 2008 Nov;33(10):1394-400
18804330
J Clin Endocrinol Metab. 1987 Jan;64(1):190-4
3536982
Science. 2000 Sep 22;289(5487):2122-5
11000114
Diabetologia. 2006 Nov;49(11):2790-2
16951936
Endocrinology. 2004 Jun;145(6):2696-701
15016717
Physiol Behav. 2000 Feb;68(4):509-14
10713291
J Clin Endocrinol Metab. 2008 Apr;93(4):1339-44
18230654
Physiol Behav. 2009 Jul 14;97(5):632-8
19351541
Nature. 1979 Nov 29;282(5738):503-5
116135
Nat Neurosci. 2002 Jun;5(6):514-6
11992114
Prog Neurobiol. 1991;36(5):343-62
1887067
Diabetes. 2004 Nov;53(11):3024-9
15504987
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12103-8
16877540
Nature. 2006 Sep 21;443(7109):289-95
16988703
Lancet. 1996 Jul 20;348(9021):159-61
8684156
Diabetes. 2000 Sep;49(9):1525-33
10969837
J Clin Invest. 1991 Oct;88(4):1272-81
1918377
Diabetes. 2006 Nov;55(11):2986-92
17065334
Horm Metab Res. 1996 Dec;28(12):664-8
9013738
J Clin Invest. 2008 Jun;118(6):2132-47
18451994
Neurology. 2008 Sep 30;71(14):1057-64
18367704
Nature. 1978 Apr 27;272(5656):827-9
205798